Skip to main content

Equities

Single stocks express views inside the circle of competence. Workflow aligns with the Investment framework thesis page and buy/sell lists.

1. Research pipeline

StageOutputTime (rough)
Screen10–20 watchlist namesBatch with data screens
Deep dive3–5 one-page theses4–8+ hours each
TrackUpdate assumptions each quarter1–2 hr/name/quarter
ExitJournal + lessonWithin 30 days of sell

2. Screening dimensions (example)

Score for ranking, not false precision.

DimensionLook atRed flags
Business modelRepeat purchase, pricing power, capex intensitySubsidy-driven growth with no path
QualityROE, CFO/NI, leverageReceivables spike; chronic negative CFO
GovernanceOwnership, related parties, dividendsRepeated dilution; broken promises
ValuationP/E, P/B, EV/EBIT percentilesHot narrative at 90th+ percentile
CatalystProduct cycle, capacity, policySingle uncontrollable bet

3. Filing read order

  1. Cash flow statement: operating CFO vs net income (≥3 years)
  2. Balance sheet: interest-bearing debt, inventory, receivables
  3. Income statement: gross margin, opex ratio; non-recurring items
  4. Notes: revenue recognition, goodwill, related parties, contingencies
  5. MD&A: consistency vs prior quarter

Ratio cheat sheet

RatioMeaningUse
ROENI / equityReturn efficiency (DuPont split)
CFO / NI>1 healthierEarnings quality
Gross margin trendYoY, QoQCompetition and pricing
Net debt / EBITDALeverageSurvival in downturn

4. Valuation: at least two methods

MethodFitsCaveat
Relative (P/E, P/B, P/S)Stable earners, good compsCyclicals distort P/E
EV/EBIT, EV/EBITDADifferent capital structuresStrip cash and debt
DCFPredictable cash flowsTerminal value sensitive—scenario it
Dividend / assetFinancials, resources, heavy assetsIndustry-specific templates

Output: bull / base / bear bands in thesis; buy nearer base–bear, sell nearer base–bull.

5. Holding-period tracking

Each quarter, update only what changed:

  • Revenue/volume vs expectation?
  • Margin and opex vs plan?
  • Competitive shift (new entrant, price war)?
  • Valuation percentile in sell zone?
  • New risks not in original thesis?

6. Sources (personal)

TypeUse
Exchange filingsGround truth
IR, earnings callsManagement narrative
Industry bodies, trade dataVolume and price
Up/downstream leadersChain cross-check

7. Relation to funds

warning

Avoid “story stocks”: narrative only, no verifiable KPIs, no valuation anchor—default to L3 watch size or pass.